Hepatitis B virus-associated hepatocellular carcinoma from India: Role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes

Journal of Gastrointestinal Cancer

Volumn 42, Issue 1, 2011, Pages 20-25

  Vivekanandan, Perumal ^a   Torbenson, Michael ^a   Ramakrishna, Banumathi ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Beta catenin; FFPE; HBV genotypes; HCC; TP53

Indexed keywords

BETA CATENIN; PROTEIN P53;

AMPLICON; ARTICLE; AUTOPSY; EXON; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS MUTATION;

ADULT; AGED; AUTOPSY; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; EXONS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INDIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952536947     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9222-4     Document Type: Article

References (38)

1. JH Kao DS Chen 2002 Global control of hepatitis B virus infection Lancet Infect 2 395 403 10.1016/S1473-3099(02)00315-8 (Pubitemid 34693257)
2. CQ Pan JX Zhang 2005 Natural history and clinical consequences of hepatitis B virus infection Int J Med Sci 2 36 40 15968338 (Pubitemid 40944951)
3. JH Kao PJ Chen MY Lai DS Chen 2000 Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B Gastroenterology 118 554 9 1:STN:280:DC%2BD3c7mslWjug%3D%3D 10.1016/S0016-5085(00)70261-7 10702206
4. HL Chan AY Hui ML Wong, et al. 2004 Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma Gut 53 1494 8 10.1136/gut.2003.033324 15361502 (Pubitemid 39265273)
5. MW Yu SH Yeh P Chen, et al. 2005 Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men J Natl Cancer Inst 97 265 72 1:CAS:528:DC%2BD2MXhsFSns78%3D 10.1093/jnci/dji043 15713961 (Pubitemid 40310274)
6. HI Yang SH Yeh PJ Chen, et al. 2008 Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 1134 43 1:CAS:528:DC%2BD1cXhtFKrsb7P 10.1093/jnci/djn243 18695135
7. S Datta 2008 An overview of molecular epidemiology of hepatitis B virus (HBV) in India Virol J 5 156 10.1186/1743-422X-5-156 19099581
8. KM Mohandas 2004 Hepatitis B associated hepatocellular carcinoma: epidemiology, diagnosis and treatment Hep B Annua 1 140 52
9. P Vivekanandan P Abraham G Sridharan, et al. 2004 Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India Clin Infect Dis 38 81 6 10.1086/383144
10. P Laurent-Puig P Legoix O Bluteau, et al. 2001 Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 120 1763 73 1:CAS:528:DC%2BD3MXkslGku7Y%3D 10.1053/gast.2001.24798 11375957 (Pubitemid 32523494)
11. DF Calvisi VM Factor S Ladu EA Conner SS Thorgeirsson 2004 Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice Gastroenterology 126 1374 86 1:CAS:528:DC%2BD2cXksF2qtbk%3D 10.1053/j.gastro.2004.02.014 15131798 (Pubitemid 38552801)
12. N Nishida T Nishimura T Nagasaka I Ikai A Goel CR Boland 2007 Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis Cancer Res 67 4586 94 1:CAS:528:DC%2BD2sXltl2hu7o%3D 10.1158/0008-5472.CAN-06- 3464 17510384 (Pubitemid 46910163)
13. CM Wong ST Fan IO Ng 2001 Beta-catenin mutation and over expression in hepatocellular carcinoma: clinicopathologic and prognostic significance Cancer 92 1 136 45 1:CAS:528:DC%2BD3MXls1enurw%3D 10.1002/1097-0142(20010701)92: 1<136::AID-CNCR1301>3.0.CO;2-R 11443619 (Pubitemid 32623050)
14. HC Hsu YM Jeng TL Mao JS Chu PL Lai SY Peng 2000 Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis Am J Pathol 157 3 763 70 1:CAS:528:DC%2BD3cXmvFWqt78%3D 10.1016/S0002-9440(10)64590-7 10980116
15. S Tanaka Y Toh E Adachi T Matsumata R Mori K Sugimachi 1993 Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation Cancer Res 53 12 2884 7 1:CAS:528:DyaK3sXlsFOhsLs%3D 8389246 (Pubitemid 23180531)
16. GD Kirk AM Camus-Randon M Mendy, et al. 2000 Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia J Natl Cancer Inst 92 2 148 53 1:CAS:528:DC%2BD3cXpt1Wqtw%3D%3D 10.1093/jnci/92.2.148 10639517 (Pubitemid 30089872)
17. M Torbenson JH Lee M Choti, et al. 2002 Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway Mod Pathol 15 189 96 10.1038/modpathol.3880514 11904335 (Pubitemid 34246615)
18. S Katiyar BC Dash V Thakur RC Guptan SK Sarin BC Das 2000 P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India Cancer 88 1565 73 1:CAS:528:DC%2BD3cXis1ensL8%3D 10.1002/(SICI)1097-0142(20000401)88: 7<1565::AID-CNCR10>3.0.CO;2-9 10738214 (Pubitemid 30183141)
19. JY Park YN Park DY Kim, et al. 2008 High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels J Viral Hepat 15 8 615 21 10.1111/j.1365-2893.2008.00989.x
20. V Thakur RC Guptan SN Kazim V Malhotra SK Sarin 2002 Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent J Gastroenterol Hepatol 17 165 70 10.1046/j.1440-1746.2002. 02605.x 11966946 (Pubitemid 34415669)
21. X Ding YN Park TC Taltavull, et al. 2003 Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries Jpn J Infect Dis 56 12 18 1:CAS:528:DC%2BD3sXks1ahur4%3D 12711820 (Pubitemid 36626515)
22. JY Park WS Park SW Nam, et al. 2005 Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis Liver Int 25 70 6 1:CAS:528:DC%2BD2MXisFCqt7s%3D 10.1111/j.1478-3231.2004.0995.x 15698401 (Pubitemid 40298247)
23. TR Devereux MC Stern GP Flake MC Yu ZQ Zhang SJ London 2001 CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1 Mol Carcinog 31 68 73 1:CAS:528:DC%2BD3MXlt1amtL8%3D 10.1002/mc.1041 11429783 (Pubitemid 32613613)
24. T Sahoo B Ramakrishna CM Habibullah DN Patil MR Das 1993 P53 mutations in human hepatocellular carcinoma in India Curr Sci 76 554 7
25. B Bressac M Kew J Wands M Ozturk 1991 Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa Nature 350 429 31 1:CAS:528:DyaK3MXitVSqs7k%3D 10.1038/350429a0 1672732 (Pubitemid 21912246)
26. RM Lunn YJ Zhang LY Wang, et al. 1997 p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan Cancer Res 57 3471 7 1:CAS:528:DyaK2sXls1Shu7w%3D 9270015 (Pubitemid 27355494)
27. L Ming SS Thorgeirsson MH Gail, et al. 2002 Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China Hepatology 36 1214 20 1:CAS:528:DC%2BD38XovFaktr8%3D 10.1053/jhep.2002.36366 12395332 (Pubitemid 35253438)
28. DA Vesey NK Hayward WG Cooksley 1994 p53 gene in hepatocellular carcinomas from Australia Cancer Detect Prev 18 123 30 1:CAS:528: DyaK2MXht1SqtA%3D%3D 8025894 (Pubitemid 2077559)
29. M Volkmann WJ Hofmann M Muller, et al. 1994 p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation Oncogene 9 195 204 1:CAS:528:DyaK2cXhs1Sit7k%3D 8302580 (Pubitemid 24020950)
30. RV Bhat S Vasanthi BS Rao, et al. 1996 Aflatoxin B1 contamination in groundnut samples collected from different geographical regions of India: a multicentre study Food Addit Contam 13 325 31 1:CAS:528:DyaK28Xis1Sgur4%3D 8718748 (Pubitemid 26140617)
31. RV Bhat S Vasanthi BS Rao, et al. 1997 Aflatoxin B1 contamination in maize samples collected from different geographical regions of India-a multicentre study Food Addit Contam 14 151 6 1:CAS:528:DyaK2sXhsFags7g%3D 9102348 (Pubitemid 27105425)
32. KG Murugavel PP Naranatt EM Shankar, et al. 2007 Prevalence of aflatoxin B1 in liver biopsies of proven hepatocellular carcinoma in India determined by an in-house immunoperoxidase test J Med Microbiol 56 1455 9 1:STN:280: DC%2BD2snktVaksQ%3D%3D 10.1099/jmm.0.47151-0 17965344 (Pubitemid 350175069)
33. IC Hsu RA Metcalf T Sun JA Welsh NJ Wang CC Harris 1991 Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature 350 427 8 1:CAS:528:DyaK3MXitVSqs7g%3D 10.1038/350427a0 1849234 (Pubitemid 21912245)
34. SS Thorgeirsson JW Grisham 2002 Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 339 46 1:CAS:528:DC%2BD38Xls1Oku7c%3D 10.1038/ng0802-339 12149612 (Pubitemid 35154440)
35. P Paterlini-Brechot K Saigo Y Murakami, et al. 2003 Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene Oncogene 22 3911 16 1:CAS:528:DC%2BD3sXks1Cnsbw%3D 10.1038/sj.onc.1206492 12813464 (Pubitemid 36819664)
36. J Wang X Chenivesse B Henglein C Brechot 1990 Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma Nature 343 555 7 1:CAS:528:DyaK3cXksFens7o%3D 10.1038/343555a0 1967822 (Pubitemid 20042714)
37. C Brechot D Gozuacik Y Murakami P Paterlini-Brechot 2000 Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) Semin Cancer Biol 10 211 31 1:CAS:528:DC%2BD3cXlsVKks74%3D 10.1006/scbi.2000.0321 10936070 (Pubitemid 30614221)
38. WJ Yang CJ Chang SH Yeh, et al. 2009 Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways Hepatology 49 5 1515 24 1:CAS:528:DC%2BD1MXlslKmur0%3D 10.1002/hep.22833 19205031